Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klara Balint

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Nature Medicine|December 25, 2007
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapyRonald J Buckanovich, Andrea Facciabene, Sarah Kim, et al.
The Journal of Clinical Investigation|October 22, 2005
Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progressionKlara Balint, Min Xiao, Chelsea C Pinnix, et al.
Nature|July 15, 2011
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cellsAndrea Facciabene, Xiaohui Peng, Ian S Hagemann, et al.
Journal of Translational Medicine|November 28, 2019
A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinomaApostolos Sarivalasis, Caroline Boudousquié, Klara Balint, et al.
Oncoimmunology|September 22, 2017
Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapyAndrea Facciabene, Francesco De Sanctis, Stefano Pierini, et al.
Frontiers in Immunology|August 24, 2019
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three PatientsMichal Bassani-Sternberg, Antonia Digklia, Florian Huber, et al.
Cancer Research|June 25, 2009
Active Notch1 confers a transformed phenotype to primary human melanocytesChelsea C Pinnix, John T Lee, Zhao-Jun Liu, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Nature Medicine|December 25, 2007
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapyRonald J Buckanovich, Andrea Facciabene, Sarah Kim, et al.
The Journal of Clinical Investigation|October 22, 2005
Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progressionKlara Balint, Min Xiao, Chelsea C Pinnix, et al.
Nature|July 15, 2011
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cellsAndrea Facciabene, Xiaohui Peng, Ian S Hagemann, et al.
Journal of Translational Medicine|November 28, 2019
A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinomaApostolos Sarivalasis, Caroline Boudousquié, Klara Balint, et al.
Oncoimmunology|September 22, 2017
Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapyAndrea Facciabene, Francesco De Sanctis, Stefano Pierini, et al.
Frontiers in Immunology|August 24, 2019
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three PatientsMichal Bassani-Sternberg, Antonia Digklia, Florian Huber, et al.
Cancer Research|June 25, 2009
Active Notch1 confers a transformed phenotype to primary human melanocytesChelsea C Pinnix, John T Lee, Zhao-Jun Liu, et al.
Pageof 2